Moolec Science SA

Moolec Science SA operates as a science-based ingredient company. It engages in the provision of produces animal proteins in plants through molecular forming. The company was founded by Gastón Paladini, Henk Hoogenkamp, and Martin Salinas on May 23, 2022 and is headquartered in Luxembourg.

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Moolec Science SA operates as a science-based ingredient company. It engages in the production of animal proteins in plants through molecular forming. The company was founded by Gastón Paladini, Henk Hoogenkamp, and Martin Salinas on May 23, 2022 and is headquartered in Luxembourg.

Moolec Science SA (NASDAQ:MLEC ) Q1 2023 Earnings Conference Call May 31, 2023 8:00 AM ET Company Participants Martín Taraciuk - Head, IR Gaston Paladini - Co-Founder, CEO & Director Amit Dhingra - Chief Science Officer Jose Lopez Lecube - CFO & Director Conference Call Participants Martín Taraciuk Good morning, and welcome to Moolec's conference call. My name is Martín Taraciuk, and I'm Moolec's Head of Investor Relations.

Moolec Science SA (MLEC) Q1 2023 Earnings Call Transcript

Bioceres Crop Solutions Corp

LUXEMBOURG / ACCESSWIRE / May 30, 2023 / Moolec Science SA (NASDAQ:MLEC) a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, today reported its business update for the third quarter of Fiscal Year 2023 ended March 31, 2023. The main highlights of the Company's business update are as follows: On January 3, the Company started trading on Nasdaq under tickers "MLEC" for the common shares, and "MLECW" for the Company's warrants.

Moolec Science Presents Third Quarter FY 2023 Business Update

LUXEMBOURG / ACCESSWIRE / May 24, 2023 / Moolec Science SA (NASDAQ: MLEC; "Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, announced today that it will release its Business Update for the third quarter of fiscal year 2023 on Tuesday, May 30, 2023, after the market closes. Moolec's Chief Executive Officer Gastón Paladini, Chief Financial Officer José López Lecube, Chief Science Officer Amit Dhingra, and Head of Investor Relations Martín Taraciuk will host a live Conference Call, followed by a question-and-answer session, on Wednesday, May 31, 2023, at 8:00 am ET.

Moolec Science to Host Third Quarter FY 2023 Business Update Call

LUXEMBOURG / ACCESSWIRE / April 17, 2023 / Moolec Science SA (NASDAQ:MLEC) ("Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, announced today it has entered into a Share Purchase Agreement ("Agreement") with Nomura Securities International, Inc. ("Nomura"). The Agreement provides for a committed equity financing facility under which the Company has the option, but not the obligation, to sell up to the equivalent of $50 million in aggregate gross purchase price of its ordinary shares to Nomura over a 36-month period, subject to the terms of the Agreement.

Moolec Science Secures Up to $50 Million in Committed Equity Financing With Nomura

LUXEMBOURG / ACCESSWIRE / April 11, 2023 / Moolec Science SA (NASDAQ:MLEC; "Company"; "Moolec"), a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, announced today the acquisition of plant-based food ingredient capabilities dedicated to the production and commercialization of functional soy proteins. This will help to accelerate Moolec's growth in the food ingredients industry by expanding its commercial network with a top-notch sales team and complementing its Molecular Farming Platform with industrial capacity, downstream operations, and a highly experienced team of professionals.

Moolec Science Acquires Food Ingredient Capabilities to Consolidate Molecular Farming Technology

LUXEMBOURG / ACCESSWIRE / April 5, 2023 / Moolec Science SA (NASDAQ:MLEC) ("Company" or "Moolec"), a Molecular Farming food-ingredient company, announced today that the Animal and Plant Health Inspection Service ("APHIS") of the U.S. Department of Agriculture ("USDA") has concluded that Moolec's GLA safflower plants pose no greater plant pest risk than non-genetically engineered safflower plants according to regulation found at 7 CFR part 340. To access the Regulatory Status Review ("RSR") response from USDA-APHIS, click here.

Moolec Science Achieves USDA-APHIS Regulatory Status Review Clearance for Molecular Farming Product

LUXEMBOURG, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Moolec Science Ltd., a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming (“Moolec UK”), and LightJump Acquisition Corporation, a publicly traded special purpose acquisition company (“LightJump”), have completed their previously announced business combination which was approved at the special meeting of LightJump stockholders on December 27, 2022. Pursuant to the transactions contemplated by the business combination agreement, Moolec UK and LightJump became wholly-owned subsidiaries of Moolec Science SA, a Luxembourg company incorporated for the purposes of the business combination (“Moolec Science”).

Molecular Farming Company Moolec Science Starts Trading on Nasdaq After Successful Closing of Business Combination

Lightjump Acquisition Corp

Following its mercurial ascent and dramatic fall from grace, special purpose acquisition companies (SPACs) again dominated headlines with LightJump Acquisition (NASDAQ: LJAQ ) initially bouncing higher on the midweek session. The blank-check firm's management team announced its shareholders approved a merger with Moolec Science, a food ingredient specialist.

Why Is LightJump Acquisition (LJAQ) Stock Trending Today?

WARWICK, United Kingdom, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Moolec Science Ltd. ("Moolec" or the "Company"), a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming, and LightJump Acquisition Corporation (Nasdaq: LJAQ; "LightJump"), a publicly traded special purpose acquisition company, today announced that their previously announced business combination (the "Business Combination") was approved at a special meeting of stockholders (the "Special Meeting") of LightJump on December 27, 2022. Approximately 92% of the votes cast at the Special Meeting were in favor of the Business Combination. LightJump plans to file the results of the Special Meeting, as tabulated by an independent inspector of elections, on a Form 8-K with the Securities and Exchange Commission (the “SEC”).

Moolec Science Ltd. Announces LightJump Acquisition Company's Shareholder Approval for Business Combination on Tuesday, December 27

News for Moolec Science SA Stock (MLEC)